Int J Cardiovasc Imaging. 2014 Jan;30(1):109-19. doi: 10.1007/s10554-013-0300-0. Epub 2013 Oct 12.
Vasodilator stress cardiac magnetic resonance (CMR) detects ischemia whereas coronary CT angiography (CTA) detects atherosclerosis. The purpose of this study was to determine concordance and accuracy of vasodilator stress CMR and coronary CTA in the same subjects. We studied 151 consecutive subjects referred to detect or exclude suspected obstructive coronary artery disease (CAD) in patients without known disease or recurrent stenosis or ischemia in patients with previously treated CAD. Vasodilator stress CMR was performed on a 1.5 T scanner. CTA was performed on a 320-detector row system. Subjects were followed for cardiovascular events and downstream diagnostic testing. Subjects averaged 56 ± 12 years (60% male), and 62 % had intermediate pre-test probability for obstructive CAD. Follow-up averaged 450 ± 115 days and was 100% complete. CMR and CTA agreed in 92% of cases (κ 0.81, p < 0.001). The event-free survival was 97 % for non-ischemic and 39% for ischemic CMR (p < 0.0001). The event-free survival was 99% for non-obstructive and 36% for obstructive CTA (p < 0.0001). Using a reference standard including quantitative invasive angiography or major cardiovascular events, CMR and CTA had respective sensitivities of 93 and 98 %; specificities of 96 and 96%; positive predictive values of 91 and 91%; negative predictive values of 97 and 99%; and accuracies of 95 and 97%. Non-ischemic vasodilator stress CMR or non-obstructive coronary CTA were highly concordant and each confer an excellent prognosis. CMR and CTA are both accurate for assessment of obstructive CAD in a predominantly intermediate risk population.
血管扩张剂负荷心脏磁共振(CMR)检测缺血,而冠状动脉 CT 血管造影(CTA)检测动脉粥样硬化。本研究的目的是确定同一受试者中血管扩张剂负荷 CMR 和冠状动脉 CTA 的一致性和准确性。我们研究了 151 例连续患者,这些患者因疑似阻塞性冠状动脉疾病(CAD)而接受检查或排除,这些患者无已知疾病或先前治疗过的 CAD 患者无再狭窄或缺血。血管扩张剂负荷 CMR 在 1.5T 扫描仪上进行。CTA 在 320 探测器列系统上进行。对受试者进行心血管事件和下游诊断检测的随访。受试者平均年龄为 56 ± 12 岁(60%为男性),62%有中度阻塞性 CAD 术前可能性。随访平均为 450 ± 115 天,且 100%完整。在 92%的病例中,CMR 和 CTA 结果一致(κ 0.81,p<0.001)。非缺血性 CMR 的无事件生存率为 97%,而缺血性 CMR 为 39%(p<0.0001)。非阻塞性 CTA 的无事件生存率为 99%,而阻塞性 CTA 为 36%(p<0.0001)。使用包括定量有创血管造影或主要心血管事件的参考标准,CMR 和 CTA 的敏感性分别为 93%和 98%;特异性分别为 96%和 96%;阳性预测值分别为 91%和 91%;阴性预测值分别为 97%和 99%;准确性分别为 95%和 97%。非缺血性血管扩张剂负荷 CMR 或非阻塞性冠状动脉 CTA 高度一致,两者均有极好的预后。在以中危人群为主的情况下,CMR 和 CTA 对评估阻塞性 CAD 均准确。